Revista: | Revista do Colegio Brasileiro de Cirurgioes |
Base de datos: | PERIÓDICA |
Número de sistema: | 000283592 |
ISSN: | 0100-6991 |
Autores: | Linhares, Eduardo1 Valadao, Marcus |
Instituciones: | 1Instituto Nacional do Cancer, Rio de Janeiro. Brasil |
Año: | 2006 |
Periodo: | Ene-Feb |
Volumen: | 33 |
Número: | 1 |
Paginación: | 51-54 |
País: | Brasil |
Idioma: | Portugués |
Tipo de documento: | Artículo |
Enfoque: | Descriptivo |
Resumen en inglés | Gastrointestinal stromal tumor (GIST) has been recently the subject of considerable clinical and experimental interest. This focus is based on insights gained during the past years concerning its identification as a distinct clinical entity and the advances in knowledge about the diagnosis and management. Historically, surgery has been considered the most effective treatment in spite of its limitations. Others therapeutic approaches have been tryng without success, until the introduction of imatinib. This drug provided hopeful results in the treatment of this neoplasia. The idea that imatinib could improve surgical outcome have led to some clinical trials with the hope that this association (imatinib & surgery) could achieve good results |
Disciplinas: | Medicina |
Palabras clave: | Cirugía, Farmacología, Neoplasias, Sistema digestivo, Sobrevivencia, Recurrencia, Imatinib, Estómago, Intestinos, Técnicas quirúrgicas, Tumor estromal |
Keyword: | Medicine, Pharmacology, Surgery, Neoplasms, Digestive tract, Survival, Recurrence, Imatinib, Stomach, Intestines, Stromal tumor, Surgical techniques |
Texto completo: | Texto completo (Ver HTML) |